EFG Asset Management Americas Corp. boosted its stake in CME Group Inc (NASDAQ:CME) by 17.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,934 shares of the financial services provider’s stock after purchasing an additional 748 shares during the period. EFG Asset Management Americas Corp.’s holdings in CME Group were worth $1,043,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Girard Partners LTD. increased its holdings in CME Group by 3.1% in the 2nd quarter. Girard Partners LTD. now owns 4,363 shares of the financial services provider’s stock valued at $847,000 after purchasing an additional 130 shares in the last quarter. Prime Capital Investment Advisors LLC boosted its position in CME Group by 59.5% in the 2nd quarter. Prime Capital Investment Advisors LLC now owns 319 shares of the financial services provider’s stock valued at $62,000 after buying an additional 119 shares during the last quarter. Doyle Wealth Management purchased a new position in CME Group in the 2nd quarter valued at about $58,000. Fox Run Management L.L.C. purchased a new position in CME Group in the 2nd quarter valued at about $571,000. Finally, Aperio Group LLC boosted its position in CME Group by 3.7% in the 2nd quarter. Aperio Group LLC now owns 210,967 shares of the financial services provider’s stock valued at $40,951,000 after buying an additional 7,573 shares during the last quarter. Hedge funds and other institutional investors own 84.77% of the company’s stock.
Shares of CME stock traded up $0.94 during trading hours on Tuesday, hitting $199.59. 7,256 shares of the company were exchanged, compared to its average volume of 1,360,243. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.04 and a current ratio of 1.04. CME Group Inc has a one year low of $161.05 and a one year high of $224.91. The business’s 50-day simple moving average is $207.91 and its two-hundred day simple moving average is $201.81. The stock has a market capitalization of $70.96 billion, a price-to-earnings ratio of 29.27, a P/E/G ratio of 3.89 and a beta of 0.18.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Tuesday, December 10th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.50%. CME Group’s payout ratio is 43.99%.
In other CME Group news, COO Julie Holzrichter sold 3,436 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $216.07, for a total value of $742,416.52. Following the transaction, the chief operating officer now owns 38,704 shares of the company’s stock, valued at $8,362,773.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Daniel R. Glickman sold 500 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total transaction of $108,005.00. Following the completion of the transaction, the director now directly owns 14,593 shares in the company, valued at approximately $3,152,233.93. The disclosure for this sale can be found here. Insiders have sold 13,636 shares of company stock worth $3,001,008 in the last ninety days. Corporate insiders own 1.20% of the company’s stock.
A number of equities analysts have weighed in on CME shares. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. UBS Group decreased their price objective on shares of CME Group from $220.00 to $218.00 and set a “neutral” rating for the company in a research report on Thursday, October 31st. Oppenheimer started coverage on shares of CME Group in a research report on Monday, September 16th. They issued an “outperform” rating and a $234.00 price objective for the company. Wells Fargo & Co upped their price objective on shares of CME Group from $200.00 to $205.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Finally, Berenberg Bank cut shares of CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the company from $236.00 to $227.00 in a research report on Thursday, September 19th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $203.36.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: Do You Need a Fiduciary?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.